Washington: A monoclonal antibody therapy developed by MassBiologics of the University of Massachusetts Medical School (UMMS) and tested in an animal model at the Texas Biomedical Research Institute, prevents infection by the hepatitis C virus (HCV).Researchers found that the human monoclonal antibody targeting the virus protected chimpanzees from HCV infection in a dose-dependent manner in a study conducted at Texas Biomed’s Southwest National Primate Research Center in San Antonio.
Narendra Modi sent emissaries to me: Geelani
Modi to file nomination from Varanasi on April 24 : Amit Shah
Now a book from RAW, more damage awaits UPA
Vote for Supriya Sule or lose water supply, threatens Ajit Pawar